1,418
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Effects of psoralen on the pharmacokinetics of anastrozole in rats

, , , &
Pages 433-439 | Received 02 May 2018, Accepted 14 Jul 2018, Published online: 21 Oct 2018

References

  • Abubakar MB, Wei K, Gan SH. 2014. The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients. Pharmacogenet and Genomics. 24:575–581.
  • Antoniou T, Tseng AL. 2005. Interactions between antiretrovirals and antineoplastic drug therapy. Clin Pharmacokinet. 44:111–145.
  • Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175:880–885.
  • Chen CH, Hwang TL, Chen LC, Chang TH, Wei CS, Chen JJ. 2017. Isoflavones and anti-inflammatory constituents from the fruits of Psoralea corylifolia. Phytochemistry. 143:186–193.
  • Ding H, Fang L, Xin W, Tong Y, Zhou Q, Huang P. 2017. Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer. Eur J Cancer Care. 26:e12733.
  • Dong C, Xu C, Liu H, Xu S, Gao Y, Peng J. 2015. Absorption and metabolism characteristics of pristimerin as determined by a sensitive and reliable LC-MS/MS method. Fitoterapia. 106:62–67.
  • Du J, Wang CH, Yang J, He X, Han XL, Li CC, Chai X, Wang YF, Zhu Y, Li Z. 2017. Chemical constituents from the fruits of Psoralea corylifolia and their protective effects on ionising radiation injury. Nat Prod Res. DOI:10.1080/14786419.2017.1405407
  • Ellis MJ. 2017. Lessons in precision oncology from neoadjuvant endocrine therapy trials in ER + breast cancer. Breast. 34:S104–S107.
  • Gong X, Chen Y, Wu Y. 2015. Absorption and metabolism characteristics of triptolide as determined by a sensitive and reliable LC-MS/MS method. Molecules. 20:8928–8940.
  • Hao B, Chen ZW, Zhou XJ, Zimin PI, Miljanich GP, Wulff H, Wang YX. 2011. Identification of phase-I metabolites and chronic toxicity study of the Kv1.3 blocker PAP-1 (5-(4-phenoxybutoxy) psoralen) in the rat. Xenobiotica. 41:198–211.
  • Jiang J, Wang X, Cheng K, Zhao W, Hua Y, Xu C, Yang Z. 2016. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells. Mol Med Rep. 13:4745–4750.
  • Kamdem LK, Liu Y, Stearns V, Kadlubar SA, Ramirez J, Jeter S, Shahverdi K, Ward BA, Ogburn E, Ratain MJ, et al. 2010. In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. Br J Clin Pharmacol. 70:854–869.
  • Kassahun Gebremeskel A, Wijerathne TD, Kim JH, Kim MJ, Seo CS, Shin HK, Lee KP. 2017. Psoralea corylifolia extract induces vasodilation in rat arteries through both endothelium-dependent and -independent mechanisms involving inhibition of TRPC3 channel activity and elaboration of prostaglandin. Pharm Biol. 55:2136–2144.
  • Kelly CM, Buzdar AU. 2010. Anastrozole. Opin Drug Saf. 9:995–1003.
  • Liu Y, Flynn TJ. 2015. CYP3A4 inhibition by Psoralea corylifolia and its major components in human recombinant enzyme, differentiated human hepatoma HuH-7 and HepaRG cells. Toxicol Rep. 2:530–534.
  • Miyajima M, Kusuhara H, Takahashi K, Takashima T, Hosoya T, Watanabe Y, Sugiyama Y. 2013. Investigation of the effect of active efflux at the blood-brain barrier on the distribution of nonsteroidal aromatase inhibitors in the central nervous system. J Pharm Sci. 102:3309–3319.
  • Nave R, Klein S, Muller A, Chang X, Hochel J. 2018. Absence of effect of intravaginal miconazole, clindamycin, nonoxynol-9, and tampons on the pharmacokinetics of an anastrozole/levonorgestrel intravaginal ring. J Clin Pharmacol. 58:97–106.
  • Sanford M, Plosker GL. 2008. Anastrozole: a review of its use in postmenopausal women with early-stage breast cancer. Drugs. 68:1319–1340.
  • Wellington K, Faulds DM. 2002. Anastrozole: in early breast cancer. Drugs. 62:2483–2490.
  • Wilkinson K. 2004. Anastrozole (Arimidex). Clin J of Oncol Nurs. 8:87–88.